Eye colour and skin pigmentation as significant factors for refractive outcome and residual accommodation in hypermetropic children: a randomized clinical trial using cyclopentolate 1% and tropicamide 1
- PMID: 34672100
- PMCID: PMC9298034
- DOI: 10.1111/aos.15016
Eye colour and skin pigmentation as significant factors for refractive outcome and residual accommodation in hypermetropic children: a randomized clinical trial using cyclopentolate 1% and tropicamide 1
Abstract
Purpose: To compare the refractive outcome and residual accommodation with respect to various degrees of iris and skin pigmentation in hypermetropic children using 2 drops of cyclopentolate 1% (C + C) or 1 drop of cyclopentolate 1% and 1 drop of tropicamide 1% (C + T).
Methods: Two hundred fifty-one hypermetropic children were classified according to iris and skin pigmentation (light, medium, dark) and received randomized and double-blind C + C or C + T. Refractive error (spherical equivalent, SEQ) was determined using the Retinomax-K + 3. In 204 subjects, residual accommodation (RA) was determined using the PlusoptiX PowerRefractor.
Results: A linear mixed model with a light-irided and light skin-pigmented reference group receiving C + T (mean SEQ +3.10 ± 1.87D) indicated significant less hypermetropia in subjects with a dark iris having a medium- and dark-pigmented skin in C + T, -1.02 ± 0.29 (-1.59/-0.45) and -1.53 ± 0.30 (-2.10/-0.95); and in subjects having a light-, medium- and dark-pigmented skin in C + C, -0.74 ± 0.34 (-1.41/-0.06), -1.26 ± 0.30 (-1.85/-0.66) and -1.84 ± 0.30 (-2.42/-1.26). Similar findings were present for RA. Our model with a light-irided and light skin-pigmented reference group receiving C + T (mean RA +0.84 ± 0.61D) indicated significantly higher RA in dark-irided subjects with medium- and dark-pigmented skin in C + T, +1.05 ± 0.19 (+0.67/+1.43) and +1.35 ± 0.20 (+0.9/+1.74), and in C + C, +1.13 ± 0.21 (+0.71/+1.55) and +1.90 ± 0.19 (+1.51/+2.28).
Conclusions: We found solid evidence that skin pigmentation rather than iris pigmentation is the decisive factor for effectiveness of cycloplegics. Awareness of the limitations of cycloplegic regimens in dark-irided/pigmented children is needed. Our study showed that cyclopentolate 1% combined with tropicamide 1% provides more accurate refractive outcomes both statistically and clinically integrating the factor skin pigmentation for dark-irided subjects.
Keywords: cyclopentolate; cycloplegics; dark iris; hypermetropia; pigmentation; residual accommodation.
© 2021 The Authors. Acta Ophthalmologica published by John Wiley & Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation.
Figures

Similar articles
-
A randomized clinical trial using atropine, cyclopentolate, and tropicamide to compare refractive outcome in hypermetropic children with a dark iris; skin pigmentation and crying as significant factors for hypermetropic outcome.Strabismus. 2019 Sep;27(3):127-138. doi: 10.1080/09273972.2019.1629466. Epub 2019 Jun 24. Strabismus. 2019. PMID: 31234691 Clinical Trial.
-
Retinoscopy in infants using a near noncycloplegic technique, cycloplegia with tropicamide 1%, and cycloplegia with cyclopentolate 1%.Optom Vis Sci. 2001 Apr;78(4):215-22. doi: 10.1097/00006324-200104000-00010. Optom Vis Sci. 2001. PMID: 11349929 Clinical Trial.
-
Comparison of tropicamide and cyclopentolate for cycloplegic refractions in myopic adult refractive surgery patients.J Cataract Refract Surg. 2005 Apr;31(4):694-700. doi: 10.1016/j.jcrs.2004.10.068. J Cataract Refract Surg. 2005. PMID: 15899444 Clinical Trial.
-
Comparative efficacy of tropicamide 1% and cyclopentolate 1% for cycloplegic refraction: A systematic review and meta-analysis of randomized controlled trials.Optom Vis Sci. 2025 Mar 1;102(3):175-180. doi: 10.1097/OPX.0000000000002226. Epub 2025 Feb 13. Optom Vis Sci. 2025. PMID: 39937702
-
1% Cyclopentolate hydrochloride: another look at the time course of cycloplegia using an objective measure of the accommodative response.Optom Vis Sci. 1993 Aug;70(8):651-65. doi: 10.1097/00006324-199308000-00013. Optom Vis Sci. 1993. PMID: 8414387 Review.
Cited by
-
Effect of cycloplegic agents (1% cyclopentolate hydrochloride and 1% tropicamide) on anterior segment parameters.Ther Adv Ophthalmol. 2023 Jul 8;15:25158414231180984. doi: 10.1177/25158414231180984. eCollection 2023 Jan-Dec. Ther Adv Ophthalmol. 2023. PMID: 37434779 Free PMC article.
References
-
- Choi O, Choo CH & Cho SC (1964): The studies on the residual accommodation of Koreans. II. The residual accommodation under 0.5 percent scopolamine and 1 percent cyclogyl cycloplegia. Yonsei Med J 5: 62–64. - PubMed
-
- Ebri A, Kuper H & Wedner S (2007): Cost‐effectiveness of cycloplegic agents: results of a randomized controlled trial in Nigerian children. Invest Ophthalmol Vis Sci 48: 1025–1031. - PubMed
-
- Egashira SM, Kish LL, Twelker JD et al. (1993): Comparison of cyclopentolate versus tropicamide cycloplegia in children. Optom Vis Sci 1993: 1029–1036. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical